A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
AMPLIFON operates in the Medical - Instruments & Supplies industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.6B | 2.6B | 2.5B | 2.2B | 2.3B |
| Net Income | 157M | 157M | 168M | 188M | 186M |
| EPS | $0.69 | $0.69 | $0.75 | $0.83 | $0.82 |
| Free Cash Flow | 396M | 396M | 367M | 423M | 485M |
| ROIC | 22.1% | 11.3% | 12.2% | 12.0% | 11.2% |
| Gross Margin | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.83 | 0.65 | 0.77 | 1.09 |
| Dividends/Share | $0.31 | $0.31 | $0.32 | $0.27 | $0.26 |
| Operating Income | 277M | 277M | 281M | 293M | 290M |
| Operating Margin | 10.7% | 10.7% | 11.5% | 13.2% | 12.6% |
| ROE | 12.6% | 12.9% | 14.7% | 17.2% | 17.1% |
| Shares Outstanding | 226M | 226M | 224M | 225M | 225M |
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 2.3B | 2.2B | 2.5B | 2.6B | 2.6B |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 290M | 293M | 281M | 277M | 277M |
| Op. Margin | 12.6% | 13.2% | 11.5% | 10.7% | 10.7% |
| Net Income | 186M | 188M | 168M | 157M | 157M |
| Net Margin | 8.1% | 8.4% | 6.9% | 6.0% | 6.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | 11.2% | 12.0% | 12.2% | 11.3% | 22.1% |
| ROE | 17.1% | 17.2% | 14.7% | 12.9% | 12.6% |
| ROA | 4.5% | 4.8% | 4.3% | 3.8% | 3.6% |
| Cash Flow | |||||
| Op. Cash Flow | 546M | 483M | 449M | 487M | 487M |
| Free Cash Flow | 485M | 423M | 367M | 396M | 396M |
| Owner Earnings | 546M | 483M | 449M | 487M | 487M |
| CapEx | 61M | 60M | 82M | 92M | 92M |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 |
| Growth CapEx | N/A | N/A | N/A | N/A | 92M |
| D&A | 0 | 0 | 0 | 0 | 0 |
| CapEx/OCF | 11.2% | 12.4% | 18.2% | 18.8% | 18.8% |
| Capital Allocation | |||||
| Dividends Paid | 58M | 61M | 71M | 71M | 71M |
| Dividend Yield | 0.6% | 0.8% | 1.0% | 1.0% | 3.4% |
| Share Buybacks | 37M | 56M | 0 | 27M | 27M |
| Buyback Yield | 0.3% | 0.9% | 0.0% | 0.5% | 1.3% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 48M | 60K | 55M | 900K | 900K |
| Balance Sheet | |||||
| Net Debt | 876M | 652M | 561M | 717M | -312M |
| Cash & Equiv. | 317M | 189M | 210M | 312M | 312M |
| Long-Term Debt | 1.2B | 841M | 771M | 1.0B | 1.0B |
| Debt/Equity | 1.09 | 0.77 | 0.65 | 0.83 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A |
| Equity | 1.1B | 1.1B | 1.2B | 1.2B | 1.2B |
| Total Assets | 4.1B | 3.8B | 4.0B | 4.3B | 4.3B |
| Total Liabilities | 3.1B | 2.7B | 2.8B | 3.1B | 3.1B |
| Intangibles | 489M | N/A | 452M | 463M | 463M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A |
| Working Capital | -283M | -488M | -606M | -481M | -481M |
| Current Assets | 763M | 624M | 674M | 784M | 784M |
| Current Liabilities | 1.0B | 1.1B | 1.3B | 1.3B | 1.3B |
| Per Share Data | |||||
| EPS | 0.82 | 0.83 | 0.75 | 0.69 | 0.69 |
| Owner EPS | 2.43 | 2.15 | 2.01 | 2.16 | 2.16 |
| Book Value | 4.86 | 4.88 | 5.34 | 5.50 | 5.50 |
| Cash Flow/Share | 2.43 | 2.15 | 2.01 | 2.16 | 0.70 |
| Dividends/Share | 0.26 | 0.27 | 0.32 | 0.31 | 0.31 |
| Shares Out. | 224.8M | 224.7M | 223.9M | 225.8M | 225.8M |
| Valuation | |||||
| P/E Ratio | 61.0 | 34.9 | 46.4 | 37.2 | 13.3 |
| P/FCF | 23.2 | 15.4 | 21.1 | 14.7 | 5.2 |
| EV/EBIT | 41.7 | 24.4 | 29.6 | 23.6 | 6.4 |
| Price/Book | 10.3 | 5.9 | 6.5 | 4.7 | 1.7 |
| Price/Sales | 4.9 | 2.9 | 3.2 | 2.2 | 0.8 |
| FCF Yield | 4.3% | 6.5% | 4.7% | 6.8% | 19.1% |
| Market Cap | 11.2B | 6.5B | 7.8B | 5.8B | 2.1B |
| Avg. Price | 46.05 | 34.06 | 32.79 | 32.02 | 9.20 |
| Year-End Price | 49.92 | 28.90 | 34.65 | 25.81 | 9.20 |
AMPLIFON passes 4 of 9 quality checks, suggesting mixed fundamentals.
AMPLIFON trades at 13.3x trailing earnings, compared to its 15-year median P/E of 41.8x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 5.2x vs a median of 18.2x. The company's 5-year average ROIC is 11.7%. Total shareholder yield (dividends + buybacks) is 4.7%. At current prices, the estimated annualized return to fair value is -4.3%.
AMPLIFON (AMP-MI) has a current P/E ratio of 13.3, compared to its historical median P/E of 41.8. The stock is currently considered Cheap based on its historical valuation range.
AMPLIFON (AMP-MI) has a 5-year average return on invested capital (ROIC) of 11.7%. This indicates solid capital allocation.
AMPLIFON (AMP-MI) has a market capitalization of $2.1B. It is classified as a mid-cap stock.
Yes, AMPLIFON (AMP-MI) pays a dividend with a trailing twelve-month yield of 3.41%. The company also returns capital through share buybacks, with a buyback yield of 1.32%.
Based on historical P/E analysis, AMPLIFON (AMP-MI) appears cheap. The current P/E of 13.3 is 68% below its historical median of 41.8. The estimated fair value CAGR (P/E method) is -2.5%.
AMPLIFON (AMP-MI) operates in the Medical - Instruments & Supplies industry, within the Healthcare sector.
AMPLIFON (AMP-MI) reported annual revenue of $2.6 billion in its most recent fiscal year, based on SEC EDGAR filings.
AMPLIFON (AMP-MI) has a net profit margin of 6.0%. This is a modest margin.
AMPLIFON (AMP-MI) generated $396 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
AMPLIFON (AMP-MI) has a debt-to-equity ratio of 0.83. This indicates moderate leverage.
AMPLIFON (AMP-MI) reported earnings per share (EPS) of $0.69 in its most recent fiscal year.
AMPLIFON (AMP-MI) has a return on equity (ROE) of 12.9%. This indicates moderate shareholder returns.
The Ledger Terminal provides 4 years of financial data for AMPLIFON (AMP-MI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
AMPLIFON (AMP-MI) has a book value per share of $5.50, based on its most recent annual SEC filing.